Recombinant in Medical News
Navigation Links
Recombinant in Medical News
...
SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
... to chemical nerve agents
RypVax(TM) - a recombinant dual antigen vaccine for plague
For ... the HHS Request for Proposals for an Anthrax recombinant Protective Antigen (rPA) Vaccine for the ...
... studies showed that sucrose-formulated recombinant factor VIII (rFVIII-FS) reduced bleeding and ... Post-marketing experience with sucrose-formulated recombinant factor VIII in patients with hemophilia A. ... : Inhibitor formation with sucrose-formulated recombinant factor VIII in patients with hemophilia A: ...
... by: Developing a long-acting recombinant factor VIII product to assess the safety and ... trials. Developing a next-generation recombinant factor VIIa protein that may provide additional ... Applying innovative technologies to develop a recombinant factor VIII molecule with potentially improved ...
... Biology showing the benefit of using recombinant lactoferrin (Lacromin) to promote growth of HEK ... derived from colostrum and has been made using recombinant techniques in an animal-free system by InVitria ... The peer-reviewed study showed that recombinant lactoferrin (Lacromin) was used as a serum-free ...
... today announced that Helixate(R) FS, its advanced recombinant FVIII (rFVIII) product for the treatment of ... patients to log infusions and treatments with recombinant FVIII Helixate FS. "Combining Helixate FS with ... About Helixate(R) FS Helixate(R) FS is a recombinant factor VIII treatment for hemophilia A that ...
... noted today that prGCD, the Company's proprietary recombinant form of Glucocerebrosidase (GCD), which is used ... development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its ... a proprietary method for the expression of recombinant proteins that Protalix believes is safe and ...
... factor. FVIII is concentrated from donated blood or is manufactured using recombinant technology, and can be given to hemophiliacs to restore hemostasis. ... manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the ...
... Sullivan Suraj Ramanathan. "The AESKU tests are developed based on human recombinant antigens or native antigens (conformational epitopes) depending on the ... the company provides more than 100 CE marked kits incorporating human recombinant antigens synthesized in-house to assure maximum sensitivity and ...
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
... Lilly) Forteo((R)) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar((R)) ... Humalog((R)) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin((R)) (human insulin of recombinant DNA origin, Lilly) Posilac((R) )(recombinant ...... studies showed that sucrose-formulated recombinant factor VIII (rFVIII-FS) reduced bleeding and ... Post-marketing experience with sucrose-formulated recombinant factor VIII in patients with hemophilia A. ... : Inhibitor formation with sucrose-formulated recombinant factor VIII in patients with hemophilia A: ...
Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
... the Phase 1 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of ... About PEG-PAL PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) is an ... product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in ...Researchers design unique method to induce immunity to certain STDs
... order to induce immunity. The team produced recombinant vaults through a process that involved the ... "Our research team wanted to find out if recombinant vaults could provide such protection by ... Kelly said. The internal cavity of the recombinant vault nanoparticle is large enough to hold ...Protein Sciences Corporation Appoints New Board of Directors
... vaccines and biopharmaceuticals. PSC uses recombinant DNA technology to make novel human and veterinary ... ingredients in all of the firm's products are recombinant proteins that are manufactured, using its ... Company's lead product is FluBlok(R), a seasonal recombinant trivalent influenza vaccine, consisting of ...InVitria Reveals Technology to Optimize Hybridoma Production Performance
... of Bioprocessing Journal reports InVitria's recombinant human serum albumin (Cellastim) and recombinant lactoferrin (Lacromin) cell culture supplements ... but also outperform other sources of native and recombinant albumin." To obtain a copy of the ...Lilly Reports Strong First-Quarter 2009 Results
... Lilly) Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar(R) ... Lilly) Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) Posilac(R) (recombinant ...... by: Developing a long-acting recombinant factor VIII product to assess the safety and ... trials. Developing a next-generation recombinant factor VIIa protein that may provide additional ... Applying innovative technologies to develop a recombinant factor VIII molecule with potentially improved ...
InVitria Announces Launch of Recombinant Albumin for Diagnostics
... InVitria's recombinant Albumin-DX eliminates safety concerns, stabilizes ... the commercial launch of two protease-free recombinant albumin products. InVitria's recombinant Albumin-DX ...PharmAthene Reports Year End 2008 Financial Results
... whether SparVax(TM), our novel second generation recombinant protective antigen vaccine candidate, has been ... and procurement of 25 million doses of a recombinant protective antigen vaccine for the Strategic ... SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine ...Repligen Announces ISO 9001:2000 Certification
... RGEN ), a global leader in the manufacture of recombinant Protein A products, announced today that the ... Repligen is the world's leading supplier of recombinant Protein A, a consumable used in the manufacture ... addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the ...Lilly Reports Fourth-Quarter and Full-Year 2008 Results
... Lilly) Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar(R) ... Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) Posilac(R) (recombinant ...... Biology showing the benefit of using recombinant lactoferrin (Lacromin) to promote growth of HEK ... derived from colostrum and has been made using recombinant techniques in an animal-free system by InVitria ... The peer-reviewed study showed that recombinant lactoferrin (Lacromin) was used as a serum-free ...
InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
... pipeline and was developed using new recombinant methods to produce a DXL(TM) anti CD20 antibody. ... of multiple candidates. Use of recombinant methods to develop DXLr120 with our patented ... Antibody Therapeutics for Cancer. About recombinant Antibodies Antibodies are protein molecules ...Corgenix Announces Expansion of Hemorrhagic Fever Virus Product Development Program
... able to provide the commercial scale-up for the recombinant protein efforts." "The addition of Vybion to ... have developed and applied for a patent for new recombinant proteins for Lassa virus. Lassa fever, a serious ... division has developed over 100 recombinant proteins in multiple expression systems including ...Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
... statements. Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) C-LLY (Logo: ...Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
... In addition, XYNTHA is the only recombinant factor VIII product to utilize an entirely ... Until now, the purification process for all recombinant factor VIII products used monoclonal antibodies ... patients because it establishes a new standard in recombinant factor VIII product purification ...Veterinary researchers study poultry virus as human cancer treatment
... Reverse genetics is the process of generating a recombinant virus from cloned complimentary DNA or cDNA copy, ... Subbiah. Through the reverse genetics system, recombinant viruses can be designed to have specific ... which are then transferred faithfully to the recombinant virus. This differs from the previous work in ...Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
... development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its ... a proprietary method for the expression of recombinant proteins that Protalix believes is safe and ... process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs. ...Lilly Caps Successful Year with Strong Fourth-Quarter Results
... hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar(R) ... Lilly) Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) Strattera(R) (atomoxetine ...... today announced that Helixate(R) FS, its advanced recombinant FVIII (rFVIII) product for the treatment of ... patients to log infusions and treatments with recombinant FVIII Helixate FS. "Combining Helixate FS with ... About Helixate(R) FS Helixate(R) FS is a recombinant factor VIII treatment for hemophilia A that ...
Protalix BioTherapeutics Announces Resignation of Board Members
... development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its ... a proprietary method for the expression of recombinant proteins that Protalix believes is safe and ... process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs. ...... noted today that prGCD, the Company's proprietary recombinant form of Glucocerebrosidase (GCD), which is used ... development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its ... a proprietary method for the expression of recombinant proteins that Protalix believes is safe and ...
Clinical studies in the pipeline: the therapies of tomorrow in trials today
... of sunitinib (marketed as Sutent). recombinant IL-21 in combination with sorafenib: Preliminary ... trial testing a combination of sorafenib and recombinant interleukin-21. Among 11 patients with renal ... study was funded by Zymogenetics, which developed recombinant interleukin-21 (IL-21). However, at this point ...Lilly Delivers Strong Third-Quarter Results
... hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin injection, Lilly) Gemzar(R) ... Lilly) Humalog(R) (insulin lispro injection of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin, Lilly) KwikPen(TM) Strattera(R) ...Baxter Reports Strong Third Quarter Sales and Earnings
... 5, 6, 8, 9 and 11 below. (2) Includes sales of recombinant FVII products (ADVATE and RECOMBINATE). Sales of recombinant FIX (BeneFIX) were previously reported in ... sales of plasma to third parties, and recombinant FIX (BeneFIX). Sales ...Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
... and commercialization of proprietary recombinant therapeutic proteins to be expressed through its ... a proprietary method for the expression of recombinant proteins that Protalix believes is safe and ... cost-effective, industrial-scale production of recombinant therapeutic proteins. Protalix has ...FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)
... with filter and other materials necessary for safe reconstitution and fast recombinant factor VIII treatment in a small, tamper-evident box with ... Kogenate(R) FS, antihemophilic factor (recombinant) , is a recombinant factor VIII treatment indicated for the control and prevention of bleeding ...PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach
... parasite, Plasmodium falciparum. This approach uses Crucell's proprietary recombinant adenoviruses (a type of virus associated with the common cold and other ... 2025," said MVI Director, Dr. Christian Loucq. Crucell is developing a recombinant malaria vaccine, Ad35-CS, based on the company's AdVac technology and ...Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
... training program, an educational initiative designed to make infusion of recombinant factor VIII easier for both patients with hemophilia A and for their ... Kogenate (R) FS, antihemophilic factor (recombinant) , is a recombinant factor VIII treatment indicated for the control and prevention of bleeding ...Research suggests new cellular targets for HIV drug development
... made up of slightly different sets of genes. A high frequency of such recombinant viruses was also found in tissues generally associated with disease ... be implicated in tumor-producing mechanisms. The higher frequency of recombinant virus in diseased tissues likely is because macrophages multiply as a ...3SBio Inc. Announces Unaudited First Quarter 2009 Results
... 2009 Business Highlights: -- EPIAO, the Company's flagship injectable recombinant human erythropoietin ("EPO") products, demonstrated resilient ... quarter of 2009. TPIAO, the Company's protein-based therapeutic recombinant human thrombopoietin ("TPO") products, demonstrated its continued ...Amgen Highlights Data to Be Presented at ASCO
... apoptosis selectively in cancer cells, and dulanermin (rhApo2L/TRAIL), a recombinant human protein that targets death receptors 4 and 5 (DR4 and DR5) and ... May 31, 2009, 8:00am-12:00pm) Phase 1b study of recombinant human Apo2L/TRAIL plus irinotecan and cetuximab or FOLFIRI in metastatic ...Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring
... deficient or defective factor IX. About Helixate FS Helixate FS is a recombinant factor VIII product indicated for the treatment of hemophilia A that ... manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the ...... factor. FVIII is concentrated from donated blood or is manufactured using recombinant technology, and can be given to hemophiliacs to restore hemostasis. ... manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the ...
CSL Behring to Launch Next GameFaces Program Challenge
... deficient or defective factor IX. About Helixate FS Helixate FS is a recombinant factor VIII product indicated for the treatment of hemophilia A that ... manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the ...New tests provide new insight into why patients are in heart failure
... "Was it when they started developing heart failure or is it genetic?" A recombinant protein also called corin identified in the late 1990s helped solve the ... wondering about the natural protein activator. She used antibodies to the recombinant protein to find the natural corin on the surface of heart cells, or ...... Sullivan Suraj Ramanathan. "The AESKU tests are developed based on human recombinant antigens or native antigens (conformational epitopes) depending on the ... the company provides more than 100 CE marked kits incorporating human recombinant antigens synthesized in-house to assure maximum sensitivity and ...
InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
... "BE FREE" t-shirt. InVitria's Cellastim Cellastim a recombinant albumin is an animal free and defined cell culture media supplement. ... and bovine serum albumin. In addition, InVitria's Lacromin Lacromin a recombinant lactoferrin is an animal free growth factor that improves cell viability ...Other ContentsmorphologymorphologymorphologymorphologymorphologymossmosaicismmotifmotifmotifmotifmotormotormotormotormotormotormotormotormotormucosamucosamucosamucosamucosafamilyfamilyfamilyfamilyfamilyfamilyfamilyfamilyfamilyfamilyOther TagsevoevoevoevoevoevoevoevothingthingthingthingeasyeasyeasyeasyOther Tagssigned 2signed 3signed 4signed 5signed 6signed 7signed 8signed 9signed 10overeating 2trip 2trip 3trip 4trip 5underground 2engage 2engage 3engage 4figure 2figure 3figure 4figure 5figure 6figure 7figure 8last 2last 3last 4last 5last 6last 7last 8last 9last 10
(Date:11/30/2009)..., N.J. - The inaugural Global Conference on Syste...2009, in Washington, DC, focuses on the convergenc...f critical importance to society. , The goal...arch activity around targeted complex systems, exa...s topic includes Critical Infrastructure Systems, ...
(Date:11/30/2009)... obstacle to HIV research is the virus,s exquisite...cientists, traditional tools, like the humble lab ...a team of researchers writing in BioMed Central,s ...nious assault on this problem by creating a mouse ...ng infected with HIV. , George Kassiotis, from t...
(Date:11/30/2009)... is a colorless and odorless radioactive gas that ...dium is a product of uranium decay and is found in...s, and groundwater as well as building materials, ...ncentration is expressed as the amount of radiatio...ducts in a liter of air; thus the units are picocu...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2A reductionist approach to HIV research 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 1Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 2Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 3Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 4Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 5Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 6Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 7Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 1Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 2Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 3Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 4Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 5Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 6Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 7Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 8Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 9Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 10Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 11Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 12Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 13Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 14Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 15Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 16Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 17Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 18Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 19Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 20Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 21Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 22Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 23Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 24Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 25Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 26Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To 241 29 52833 27Safe Ozone Levels May Not Be for Some 52829 1Safe Ozone Levels May Not Be for Some 52829 2(Date:12/2/2009)... detailing plastic surgery procedures is now avail...ndidates can view procedures and print out informa... (PRWEB) December 2, 2009 -- Recov...ler, has always been dedicated to providing resour...dures, providing liposuction garments, breast augm...
(Date:12/2/2009)...g author James A. Feinstein, MD, has just released...sons from Patients on Becoming a Doctor, that trac... school--the grueling clinical year. , ..., 2009 -- Most people will, at some point or anoth...tal gown or staring at someone else dressed in a t...
(Date:12/2/2009)...wire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq:...fray Health Care Conference today at 2:30 p.m. Eas...cast live and may be accessed through a link on th....gen-probe.com . The webcast will be available for...be ,, Gen-Probe Incorporated is a global lead...
(Date:12/2/2009)...ewswire/ -- LeapFrog Investments has announced a Z...lLife, the innovative South African insurer servin...ent brings together LeapFrog, the leading microins...,s most innovative insurance businesses. The annou...lLife has developed a distinctive and profitable b...
(Date:12/2/2009)...inical trial presented today at the annual meeting...A) provide the first strong evidence of the benefi...nse breasts who are at elevated risk for breast ca... highly sensitive in depicting early breast cancer...und in addition to mammography significantly impro...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2[0] Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures [0] Beneath the Short White Coat: A Medical Student Reveals All[0] Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today[0] LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer[0] Annual screening with breast ultrasound or MRI could benefit some women
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |